Amenorrhea, Anovulation, and Dysfunctional Uterine Bleeding

Endocrinology: Adult and Pediatric, Sixth Edition

Volumn 2, Issue , 2010, Pages 2341-2355

  Illingworth, Peter ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906240872     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5583-9.00129-5     Document Type: Chapter

References (113)

1. R Short (1984) Oestrus and menstrual cycles. C Austin, R Short,(Eds) Hormonal control of reproduction Cambridge: Cambridge University Press 115-152.
2. PW Howie and AS McNeilly (1982) Effect of breast-feeding patterns on human birth intervals. J Reprod Fertil 65 545-557.
3. I Fraser, M Hickey (1998) Dysfunctional uterine bleeding. I Fraser, R Jansen, R Lobo, et al., (Eds) Estrogens and progestogens in clinical practice London: Churchill Livingstone 419-436.
4. M Hickey and A Balen (2003) Menstrual disorders in adolescence: investigation and management. Hum Reprod Update 9 493-504.
5. N Santoro (2002) The menopause transition: an update. Hum Reprod Update 8 155-160.
6. PM Motta, S Makabe and SA Nottola (1997) The ultrastructure of human reproduction. I. The natural history of the female germ cell: origin, migration and differentiation inside the developing ovary. Hum Reprod Update 3 281-295.
7. KP McNatty, DA Heath, T Lundy, et al. (1999) Control of early ovarian follicular development. J Reprod Fertil Suppl 54 3-16.
8. JA Elvin and MM Matzuk (1998) Mouse models of ovarian failure. Rev Reprod 3 183-195.
9. DT Baird (1988) The primate ovary: critique and perspectives. RL Stouffer,(Eds) The primate ovary New York and London: Plenum Press 249-259.
10. SG Hillier and M Tetsuka (1997) Role of androgens in follicle maturation and atresia. Baillieres Clin Obstet Gynaecol 11 249-260.
11. JS Richards, DL Russell, S Ochsner, et al. (2002) Ovulation: new dimensions and new regulators of the inflammatory-like response. Annu Rev Physiol 64 69-92.
12. WC Duncan (2000) The human corpus luteum: remodelling during luteolysis and maternal recognition of pregnancy. Rev Reprod 5 12-17.
13. RW Noyes, AT Hertig and J Rock (1950) Dating the endometrial biopsy. Fertil Steril 1 23-25.
14. RW Kelly, AE King and HO Critchley (2001) Cytokine control in human endometrium. Reproduction 121 3-19.
15. DT Baird (1997) Amenorrhoea. Lancet 350 275-279.
16. G Leyendecker and L Wildt (1983) Induction of ovulation with chronic intermittent (pulsatile) administration of Gn-RH in women with hypothalamic amenorrhoea. J Reprod Fertil 69 397-409.
17. WF Crowley Jr, M Filicori, DI Spratt, et al. (1985) The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 41 473-531.
18. RE Blackwell (1985) Diagnosis and treatment of hyperprolactinemic syndromes. Obstet Gynecol Annu 14 310-327.
19. DL Kleinberg, GL Noel and AG Frantz (1977) Galactorrhea: a study of 235 cases, including 48 with pituitary tumors. N Engl J Med 296 589-600.
20. CC Tay, AF Glasier, PJ Illingworth, et al. (1993) Abnormal twenty-four hour pattern of pulsatile luteinizing hormone secretion and the response to naloxone in women with hyperprolactinaemic amenorrhoea. Clin Endocrinol (Oxf) 39 599-606.
21. A Grossman, PJ Moult, H McIntyre, et al. (1982) Opiate mediation of amenorrhoea in hyperprolactinaemia and in weight-loss related amenorrhoea. Clin Endocrinol (Oxf) 17 379-388.
22. JR Davis (2004) Prolactin and reproductive medicine. Curr Opin Obstet Gynecol 16 331-337.
23. T Matsuzaki, K Azuma, M Irahara, et al. (1994) Mechanism of anovulation in hyperprolactinemic amenorrhea determined by pulsatile gonadotropin-releasing hormone injection combined with human chorionic gonadotropin. Fertil Steril 62 1143-1149.
24. PM Mah and J Webster (2002) Hyperprolactinemia: etiology, diagnosis, and management. Semin Reprod Med 20 365-374.
25. ME Molitch (2002) Medical management of prolactin-secreting pituitary adenomas. Pituitary 5 55-65.
26. NM Martin, T Tan and K Meeran (2009) Dopamine agonists and hyperprolactinaemia. BMJ 338 381.
27. RE Frisch (1985) Fatness, menarche, and female fertility. Perspect Biol Med 28 611-633.
28. GA Bray and DA York (1997) Clinical review 90: Leptin and clinical medicine: a new piece in the puzzle of obesity. J Clin Endocrinol Metab 82 2771-2776.
29. Y Zhang, R Proenca, M Maffei, et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372 425-432.
30. CK Welt, JL Chan, J Bullen, et al. (2004) Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med 351 987-997.
31. TJ Laatikainen (1991) Corticotropin-releasing hormone and opioid peptides in reproduction and stress. Ann Med 23 489-496.
32. L Wildt, G Leyendecker, T Sir-Petermann, et al. (1993) Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy. Hum Reprod 8 350-358.
33. JE Hall (1999) Physiologic and genetic insights into the pathophysiology and management of hypogonadotropic hypogonadism. Ann Endocrinol (Paris) 60 93-101.
34. F Kallman, W Schoefield and S Barrera (1944) The genetic aspects of primary eunuchoidism. Am J Ment Defic 48 203-236.
35. A Bhangoo and E Jacobson-Dickman (2009) The genetics of idiopathic hypogonadotropic hypogonadism: unraveling the biology of human sexual development. Paediatr Endocrinol Rev 6 395-404.
36. J Waldstreicher, SB Seminara, JL Jameson, et al. (1996) The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J Clin Endocrinol Metab 81 4388-4395.
37. T Laml, O Preyer, W Umek, et al. (2002) Genetic disorders in premature ovarian failure. Hum Reprod Update 8 483-491.
38. G Perez, CM Knudson, L Leykin, et al. (1998) Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nat Med 3 1228-1232.
39. ML DeBruin, E Van Dulmen-den Broeder, MH Van den Berg, et al. (2009) Fertility in female childhood cancer survivors. Endocr Dev 15 135-158.
40. BL Harlow and LB Signorello (2000) Factors associated with early menopause. Maturitas 35 3-9.
41. JC Morrison, JR Givens, WL Wiser, et al. (1975) Mumps oophoritis: a cause of premature menopause. Fertil Steril 26 655-659.
42. H Turner (1938) A syndrome of infantilism, congenital webbed neck and cubitus valgus. Endocrinology 23 566-568.
43. CH Gravholt, S Juul, RW Naeraa, et al. (1996) Prenatal and postnatal prevalence of Turner's syndrome: a registry study. BMJ 312 16-21.
44. A Marchini, G Rappold and KU Schneider (2007) SHOX at a glance: from gene to protein. Arch Physiol Biochem 113 116-123.
45. KA Leppig and CM Disteche (2001) Ring X and other structural X chromosome abnormalities: X inactivation and phenotype. Semin Reprod Med 19 147-157.
46. K Reynaud, R Cortvrindt, F Verlinde, et al. (2004) Number of ovarian follicles in human fetuses with the 45,X karyotype. Fertil Steril 81 1112-1119.
47. MF Karnis, AE Zimon, SI Lalwani, et al. (2003) Risk of death in pregnancy achieved through oocyte donation in patients with Turner syndrome: a national survey. Fertil Steril 80 498-501.
48. G Swyer (1955) Male pseudohermaphroditism: a hitherto undescribed form. BMJ ii 709-712.
49. RS Hines, SP Tho, YY Zhang, et al. (1997) Paternal somatic and germ-line mosaicism for a sex-determining region on Y (SRY) missense mutation leading to recurrent 46,XY sex reversal. Fertil Steril 67 675-679.
50. PN Goodfellow and R Lovell-Badge (1993) SRY and sex determination in mammals. Annu Rev Genet 27 71-92.
51. JW Foster, MA Dominguez-Steglich, S Guioli, et al. (1994) Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372 525-530.
52. ST Warren and CT Ashley Jr (1995) Triplet repeat expansion mutations: the example of fragile X syndrome. Annu Rev Neurosci 18 77-99.
53. JJ De Caro, C Dominguez and SL Sherman (2008) Reproductive health of adolescent girls who carry the FMR1 premutation: expected phenotype based on current knowledge of fragile X-associated primary ovarian insufficiency. Ann N Y Acad Sci 1135 99-111.
54. FR Kaufman, MD Kogut, GN Donnell, et al. (1981) Hypergonadotropic hypogonadism in female patients with galactosemia. N Engl J Med 304 994-998.
55. K Aittomaki, JL Lucena, P Pakarinen, et al. (1995) Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82 959-968.
56. G Meduri, A Bachelot, MP Cocca, et al. (2008) Molecular pathology of the FSH receptor: new insights into FSH physiology. Mol Cell Endocrinol 282 130-142.
57. AC Latronico, J Anasti, IJ Arnhold, et al. (1996) Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 334 507-512.
58. A Morishima, MM Grumbach, ER Simpson, et al. (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80 3689-3698.
59. WJ Irvine, MM Chan, L Scarth, et al. (1968) Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease. Lancet 2 883-887.
60. A Hoek, J Schoemaker and HA Drexhage (1997) Premature ovarian failure and ovarian autoimmunity. Endocr Rev 18 107-134.
61. Z Blumenfeld, S Halachmi, BA Peretz, et al. (1993) Premature ovarian failure—the prognostic application of autoimmunity on conception after ovulation induction. Fertil Steril 59 750-755.
62. RJ Aitken, M Paterson and M van Duin (1996) The potential of the zona pellucida as a target for immunocontraception. Am J Reprod Immunol 35 175-180.
63. NJ Wheatcroft, C Salt, A Milford-Ward, et al. (1997) Identification of ovarian antibodies by immunofluorescence, enzyme-linked immunosorbent assay or immunoblotting in premature ovarian failure. Hum Reprod 12 2617-2622.
64. JS Gell (2003) Mullerian anomalies. Semin Reprod Med 21 375-388.
65. D Yu, YM Wong, Y Cheong, et al. (2008) Asherman syndrome—one century later. Fertil Steril 89 759-779.
66. C Sultan, S Lumbroso, F Paris, et al. (2002) Disorders of androgen action. Semin Reprod Med 20 217-228.
67. J Morris (1953) The syndrome of testicular feminization in male pseudohermaphrodites. Am J Obstet Gynecol 65 1192-1211.
68. MJ McPhaul (2002) Androgen receptor mutations and androgen insensitivity. Mol Cell Endocrinol 198 61-67.
69. DA Koutras (1997) Disturbances of menstruation in thyroid disease. Ann N Y Acad Sci 816 280-284.
70. EC Ridgway, C Longcope and F Maloof (1975) Metabolic clearance and blood production rates of estradiol in hyperthyroidism. J Clin Endocrinol Metab 41 491-497.
71. J Fishman, L Hellman, B Zumoff, et al. (1962) Influence of thyroid hormone on estrogen metabolism in man. J Clin Endocrinol Metab 22 389-392.
72. MA Magiakou, G Mastorakos, E Webster, et al. (1997) The hypothalamic-pituitary-adrenal axis and the female reproductive system. Ann N Y Acad Sci 816 42-56.
73. I Stein and M Leventhal (1935) Amenorrhoea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29 181-191.
74. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 19-25.
75. AH Balen, JS Laven, SL Tan, et al. (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9 505-514.
76. S Sam and A Dunaif (2003) Polycystic ovary syndrome: syndrome XX? Trends Endocrinol Metab 14 365-370.
77. RJ Norman, M Noakes, R Wu, et al. (2004) Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update 10 267-280.
78. VL Nelson, RS Legro, JF Strauss 3rd, et al. (1999) Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 13 946-957.
79. JF Strauss 3rd (2003) Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome. Ann N Y Acad Sci 997 42-48.
80. R Azziz (2003) The evaluation and management of hirsutism. Obstet Gynecol 101 995-1007.
81. E Adashi (1996) Ovulation induction: clomiphene citrate. E Adashi, J Rock, Z Rosenwaks,(Eds) Reproductive endocrinology, surgery and technology Philadelphia: Lippincott-Raven 1181-1206.
82. AF Glasier, DS Irvine, EJ Wickings, et al. (1989) A comparison of the effects on follicular development between clomiphene citrate, its two separate isomers and spontaneous cycles. Hum Reprod 4 252-256.
83. R Homburg (2003) The management of infertility associated with polycystic ovary syndrome. Reprod Biol Endocrinol 1 109.
84. MF Mitwally and RF Casper (2001) Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 75 305-309.
85. MA Rossing, JR Daling, NS Weiss, et al. (1994) Ovarian tumors in a cohort of infertile women. N Engl J Med 331 771-776.
86. BC Tarlatzis, G Grimbizis, J Bontis, et al. (1995) Ovarian stimulation and ovarian tumours: a critical reappraisal. Hum Reprod Update 1 284-301.
87. JM Lord, IH Flight and RJ Norman (2003) Metformin in polycystic ovary syndrome: systematic review and meta-analysis. BMJ 327 951-953.
88. Farquhar C, Lilford R, Marjoribanks J, et al. Laparoscopic “drilling” by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome, Cochrane Database Syst Rev (3):CD001122, 2007.
89. RS Legro (2003) Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 24 302-312.
90. TC Li and ID Cooke (1991) Evaluation of the luteal phase. Hum Reprod 6 484-499.
91. J Balasch and JA Vanrell (1986) Luteal phase deficiency: an inadequate endometrial response to normal hormone stimulation. Int J Fertil 31 368-371.
92. AC Wentz, LR Kossoy and RA Parker (1990) The impact of luteal phase inadequacy in an infertile population. Am J Obstet Gynecol 162 937-943.
93. J Balasch, F Fabregues, M Creus, et al. (1992) The usefulness of endometrial biopsy for luteal phase evaluation in infertility. Hum Reprod 7 973-977.
94. MP Hamilton, R Fleming, JR Coutts, et al. (1990) Luteal phase deficiency: ultrasonic and biochemical insights into pathogenesis. Br J Obstet Gynaecol 97 569-575.
95. AS McNeilly (2001) Neuroendocrine changes and fertility in breast-feeding women. Prog Brain Res 133 207-214.
96. LM Karamardian and DA Grimes (1992) Luteal phase deficiency: effect of treatment on pregnancy rates. Am J Obstet Gynecol 167 1391-1398.
97. PR Koninckx, SH Kennedy and DH Barlow (1998) Endometriotic disease: the role of peritoneal fluid. Hum Reprod Update 4 741-751.
98. J Sirois, K Sayasith, KA Brown, et al. (2004) Cyclooxygenase-2 and its role in ovulation: a 2004 account. Hum Reprod Update 10 373-385.
99. G Smith, R Roberts, C Hall, et al. (1996) Reversible ovulatory failure associated with the development of luteinized unruptured follicles in women with inflammatory arthritis taking non-steroidal anti-inflammatory drugs. Br J Rheumatol 35 458-462.
100. J Drife (Ed.) (1989) Dysfunctional uterine bleeding and menorrhagia London: Baillière Tindall
101. A Lethaby and C Farquhar (2003) Treatments for heavy menstrual bleeding. BMJ 327 1243-1244.
102. HN Jabbour, RW Kelly, HM Fraser, et al. (2006) Endocrine regulation of menstruation. Endocr Rev 27 17-46.
103. SK Smith, MH Abel, RW Kelly, et al. (1981) Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 88 434-442.
104. KJ Sales and HN Jabbour (2003) Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction 126 559-567.
105. SK Smith, MH Abel, RW Kelly, et al. (1981) A role for prostacyclin (PGI2) in excessive menstrual bleeding. Lancet 1 522-524.
106. NC Gleeson (1994) Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia. Am J Obstet Gynecol 171 178-183.
107. PA Rogers, JF Dohoghue, LM Walter, et al. (2009) Endometrial angiogenesis, vascular maturation, and lymphangiogenesis. Reprod Sci 16 147-151.
108. Lethaby A, Farquhar C, Cooke I: Antifibrinolytics for heavy menstrual bleeding, Cochrane Database Syst Rev (4):CD000249, 2000.
109. Lethaby A, Augood C, Duckitt K, et al: Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding, Cochrane Database Syst Rev (4):CD000400, 2007.
110. Lethaby A, Irvine GA, Cameron IT: Cyclical progestogens for heavy menstrual bleeding, Cochrane Database Syst Rev (1):CD001016, 2008.
111. AM Kaunitz, S Meredith, P Inki, et al. (2009) Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis. Obstet Gynecol 113 1104-1116.
112. Beaumont HH, Augood C, Duckitt K, et al: Danazol for heavy menstrual bleeding, Cochrane Database Syst Rev (3):CD001017, 2007.
113. HM Fraser and DT Baird (1987) Clinical applications of LHRH analogues. Baillieres Clin Endocrinol Metab 1 43-70.